Sign up to view this video Join Now Clinical Operations, • 9/19/25 Optimizing CRO and Vendor Selection - Examples from the Field Previous Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Next Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources You Might Also Like Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research What Matters to Payers: Conversations You Should Start During Phase 2 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development
Sign up to view this video Join Now Clinical Operations, • 9/19/25 Optimizing CRO and Vendor Selection - Examples from the Field Previous Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Next Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources You Might Also Like Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research What Matters to Payers: Conversations You Should Start During Phase 2 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development
